CCR2 and graft versus host disease: Additionally, in a xenograft experiment using CCR2 gene knockout donors, the infiltration of CCR2−/− CD8+ T cells in the intestines and livers of recipient mice decreased, leading to reduced pathological damage in target organs and an overall decrease in the incidence and mortality of acute GVHD, while retaining the intact GVL (35).